Despite Sanofi CEO Paul Hudson’s confidence in vaccines, the French pharma has cut at least one mRNA flu shot program.
The company, however, continues to work on a phase 1/2 study of its H5 mRNA flu vaccine for pandemic preparedness.
A fast-spreading new flu strain is gaining a reputation as a monstrous “super flu.” The mutation of influenza A(H3N2) called subclade K is driving up infections across the country, including in New ...
Two and a half years after Sanofi unveiled to investors a revamped strategy to create an mRNA seasonal flu vaccine, Fierce Biotech has learned that the French pharma has put this pipeline on ice.
Medical experts debunk flu shot myths: vaccines use inactive virus that cannot cause illness. Discover what side effects actually mean for your immunity.
SHELTON, CONNECTICUT / ACCESS Newswire / January 13, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a ...
Trump administration officials have been promoting the new guidelines, which emphasize protein and urge Americans to limit or ...
All viral activity benchmarks have gone down, except for a slight increase in the death rate. Here's what to know about the state of the flu season.
The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.
Worcester Telegram on MSN
Which flu type is going around in 2026? Difference between Type A, B
Feeling under the weather? You could have Influenza Type A. Here's the difference between Influenza Type A and Type B.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results